BRIV_adv
Annals of Indian Academy of Neurology
  Users Online: 469 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size

Table of Contents
LETTERS TO THE EDITOR
Year : 2021  |  Volume : 24  |  Issue : 4  |  Page : 593
 

Epilepsy care- awarness, cost and availability of antiepileptic drugs


Department of Neurology, Dr. S.N. Medical College, Jodhpur, Rajasthan, India

Date of Submission25-Aug-2020
Date of Acceptance11-Sep-2020
Date of Web Publication04-Feb-2021

Correspondence Address:
Dr. Khichar Shubhakaran
House No. E-22/13, Umaid Hospital Campus, GEETA BHAWAN, Road, Jodhpur, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.AIAN_926_20

Rights and Permissions

 



How to cite this article:
Shubhakaran K. Epilepsy care- awarness, cost and availability of antiepileptic drugs. Ann Indian Acad Neurol 2021;24:593

How to cite this URL:
Shubhakaran K. Epilepsy care- awarness, cost and availability of antiepileptic drugs. Ann Indian Acad Neurol [serial online] 2021 [cited 2021 Oct 25];24:593. Available from: https://www.annalsofian.org/text.asp?2021/24/4/593/308701




Dear Editor

I read an editorial on interesting aspect of cheap and easy availability of antiepileptic drugs (AEDs) for the betterment of care of epilepsy patients by Keni and Thomas.[1] The epilepsy can be controlled in approximately 70% of the patient but in our country the 70% of epilepsy patients remain uncontrolled or country accounts for about 20% of uncontrolled or partially controlled epilepsy,[2] it will have an immense impact on large number of patients (approximately 10 million) along with positive financial impact with a geographical disparities[3]. As per the World Health Organization the Southeast Asian Region (SEARO) no patient with epilepsy (PWE) be left untreated or uncontrolled of seizures.[4]

The biggest factor for all these healthcare implications is poverty or lack of adequate funds with the government along with lack of awareness. In the study by Singh et al.[5] the authors have found major problems of availability, affordability, and other aspects for the management of PWE.

Way back to 1931 (as per documentation) till now, the debate for the drug or treatment of the diseases that it should be in favor of the patients rather than the drug-producing unit or the treating institute or the clinician.[6] In some states like Rajasthan, there is free drug supply schemes including AEDs along with many other essential and common important drugs along with public awareness on print and electronic media and of course the patients by themselves in turn.[7] It helps the patients get free medicines, investigations, and other supportive therapies as this aspect has been studied in stroke patients recently.[8]

The implementation of such schemes at the national on rather at international levels can help a lot to the PWEs. Various neurological and epilepsy societies/bodies may mobilize the governments or nongovernmental organizations in this direction.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Keni RR, Thomas S V. Bridging the gap in epilepsy treatment in a resource-limited setting. Ann Indian Acad Neurol 2020;23:427. doi: 10.4103/aian.AIAN_608_19.  Back to cited text no. 1
  [Full text]  
2.
Amudhan S, Gururaj G, Satishchandra P. Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol 2015;18:263-77.  Back to cited text no. 2
[PUBMED]  [Full text]  
3.
Meyer AC, Dua T, Ma J, Saxena S, Birbeck G. Global disparities in the epilepsy treatment gap: A systemic review. Bull World Health Organ 2010;88:260-6.  Back to cited text no. 3
    
4.
Epilepsy In The South-East Asia Region. Bridging the Gap. World Health Organization; 2017. Available from: https://www.who.int/mental_health/neurology/epilepsy/searo_report.pdf?ua=1. [Last accessed on 2019 Nov 15].  Back to cited text no. 4
    
5.
Singh K, Setia RK, Sharma S, Bansal N, Bansal RK, Chaudhary A, et al. Antiepileptic drug prices, availability and affordability in a resource-limited setting. Ann Indian Acad Neurol 2020. doi: 10.4103/aian.AIAN_264_19.  Back to cited text no. 5
    
6.
Shubhakaran K, Khichar RJ. Current controversies: Physicians vs Pharma. Neurol Clin Pract 2014;4:374-5.  Back to cited text no. 6
    
7.
8.
Goswami D, Singh K, Bhardwaj P, Panda S, Goel A, Joshi N, et al. Economic burden of acute stroke care in beneficiaries and non-Beneficiaries under social security schemes at Tertiary Care Hospitals of Western Rajasthan. Ann Indian Acad Neurol 2020. doi: 10.4103/aian.AIAN_393_19.  Back to cited text no. 8
    




 

Top
Print this article  Email this article

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (345 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed358    
    Printed13    
    Emailed0    
    PDF Downloaded34    
    Comments [Add]    

Recommend this journal